Unlicensed Filler Product: Why It Is a Risk of Its Own

The risk of an unlicensed filler product is separate from, and independent of, the question of who injects it. Even a capable doctor finds their hands tied when facing a product whose contents are unknown. This article sets out where the risk gathers, how it is spotted and what should be asked.

What does licensing mean?

Short answer: In Türkiye the licensing of medicines and medical devices sits with TİTCK. Which category a product falls into, and whether it may be placed on the market, is read from that registry.

Licensing does not mean a product will give a result in every case. Its meaning is more basic: what the product is, what its contents carry and how it must be stored are all on record.

That record is what makes it possible to know what you are dealing with when something goes wrong. Where the record does not exist, neither does the knowledge.

Traceability depends on it too. A batch number being written down makes every later assessment easier and faster.

Where does the risk gather?

The first risk is the contents. Placing a substance of unknown composition into skin carries the possibility of an unpredictable reaction, and that possibility cannot be assessed beforehand.

The second is persistence. Some unlicensed products can remain in tissue far longer than expected, and removing them becomes a problem in its own right.

The third is management. How a complication is handled depends on what the product is; when the contents are unknown, the approach becomes uncertain too.

How is it spotted?

Short answer: The product not being named, the box not being shown and the packaging not being opened in front of you are the clearest signs. Those requests are ordinary and should not create discomfort.

Being told a product name may not be enough on its own. Seeing the box, the expiry date and any batch number gives something more concrete.

An unusually low price is a sign too; what lowers the cost is usually a corner cut somewhere. We covered the wider picture in unlicensed aesthetic practice.

Why is permanent filler discussed separately?

Products described as permanent sit under their own heading because they are not reversible when something goes wrong. A result you dislike, or a complication, cannot easily be corrected.

So when "permanent" is presented as an advantage, what it rests on and whether it can be reversed both need asking.

Being told what the product is and how it behaves is part of consent as well; the treatment's own page sits under lip filler.

What should you ask?

Which product will be used, may I see the box, will the packaging be opened in front of me, what is the expiry date, and is it being recorded. All five are ordinary questions.

Asking how the product is stored belongs on that list too. Storage conditions can matter as much as the product itself.

If those questions are not answered without hesitation, the answer has been given. We covered the counterfeit side in counterfeit filler risks.

What if it has already been used?

Short answer: Keeping the name of the product, the box and any paperwork is the most important step. Every later assessment moves far faster with that information.

If a finding appears, do not wait. Increasing pain, a change in colour, spreading swelling and fever are all findings that should not be left.

Even with no findings, having an assessment is useful. What is in the area being on record strengthens the plan for any treatment that follows; we covered when and how to seek help in aesthetic complication management.

If the result looks fine, is there no risk?

A good result early on does not remove the question of what the product is. Some pictures appear months later.

So the assessment does not run on appearance alone. Knowing what was used is necessary for every procedure that follows as well.

At a later treatment the doctor needs to know what is in the area. Without that, the plan is built on incomplete data — which is why keeping your own note of date, product name and area treated is worth the thirty seconds it takes.

Frequently asked questions

They tell me the product name — is that enough? A name gives limited information on its own. Seeing the box, the expiry date and any batch number is more concrete, and having the packaging opened in front of you is ordinary practice. If those requests create discomfort, that alone is a sign worth assessing.

Is a product brought in from abroad safe? What decides it is not where it came from but whether it is licensed in Türkiye and how it has been stored. A product whose cold chain or storage conditions have been broken is not the same product even if it was originally licensed. So origin and storage both need asking about.

Can an unlicensed product be removed? That depends on what the product is, and with some products removal is difficult. The doctor assessing you needs to know what they are dealing with, which is why the box and the paperwork matter. The decision is made after an examination and on the basis of how much is known.

Is every cheap product unlicensed? No such equivalence can be drawn, and advertising prices in healthcare is prohibited by regulation in any case. But an unusually low cost suggests a corner was cut somewhere. Asking where that corner was is a reasonable step and an easy one to take.

---

If you would like to talk through which product will be used and whether it suits you, your medical history and expectations are assessed together at the consultation.

This article is general information, not medical advice. Assessment and treatment decisions follow a doctor's examination; results vary from person to person.